Atlas Trials

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

Clinical trial NCT07235527 · RECRUITING

Trial details

NCT number
NCT07235527
Sponsor
Saglik Bilimleri Universitesi
Status
RECRUITING
Study type
OBSERVATIONAL
Age Related Macular DegenerationExudative Age-Related Macular DegenerationAnti Vascular Endothelial Growth Factor
Start date
2025-11-20
Primary completion
2026-06-20
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.